271 related articles for article (PubMed ID: 17471442)
1. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
[TBL] [Abstract][Full Text] [Related]
2. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
3. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
5. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
[TBL] [Abstract][Full Text] [Related]
6. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.
Matte C; Olivier M
J Infect Dis; 2002 Mar; 185(5):673-81. PubMed ID: 11865425
[TBL] [Abstract][Full Text] [Related]
7. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
8. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
10. Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.
Varikuti S; Natarajan G; Oghumu S; Sperling RH; Moretti E; Stock J; Papenfuss TL; Satoskar AR
Cell Immunol; 2016 Nov; 309():61-68. PubMed ID: 27614845
[TBL] [Abstract][Full Text] [Related]
11. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
12. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
Alexander CE; Kaye PM; Engwerda CR
Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
[TBL] [Abstract][Full Text] [Related]
13. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
15. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
16. Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
Murray HW; Luster AD; Zheng H; Ma X
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795366
[TBL] [Abstract][Full Text] [Related]
17. Resistance against Leishmania donovani induced with an aluminum hydroxide vaccine.
Jarecki-Black JC; Hallman KL; James ER; Glassman AB
Ann Clin Lab Sci; 1988; 18(1):72-7. PubMed ID: 3355098
[TBL] [Abstract][Full Text] [Related]
18. rIL-2-stimulated splenocytes reactivate the NO2-producing ability of macrophages infected by Leishmania donovani.
Eslami Z; Tanner CE
Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):465-87. PubMed ID: 10946826
[TBL] [Abstract][Full Text] [Related]
19. The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.
Hassan MF; Zhang Y; Engwerda CR; Kaye PM; Sharp H; Bickle QD
Am J Pathol; 2006 Sep; 169(3):943-53. PubMed ID: 16936268
[TBL] [Abstract][Full Text] [Related]
20. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
Rezai HR; Farrell J; Soulsby EL
Clin Exp Immunol; 1980 Jun; 40(3):508-14. PubMed ID: 6968259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
